: Research from Philip Morris International's science division on its Heat-not-Burn product IQOS focused on its chemical, toxicological, clinical, and behavioral aspects. Independent research on the experiences and behavioral aspects of using IQOS, and how it compares to e-cigarettes, is largely lacking. The current randomized, cross-over behavioral trial tried to bridge the latter gaps. : Participants ( = 30) came to the lab on three consecutive days after being overnight smoking abstinent. During each session, participants used one of three products (cigarette, e-cigarette, or IQOS) for five minutes. Exhaled CO (eCO) measurements and questionnaires were repeatedly administered throughout the session. : Smoking a cigarette for five minutes resulted in a significant increase of eCO, whereas using an IQOS resulted in a small but reliable increase (0.3 ppm). Vaping did not affect eCO. Cigarette craving reduced significantly after product use, with the decline being stronger for smoking than for e-cigarettes or IQOS. Withdrawal symptoms declined immediately after smoking or using IQOS, and with some delay after vaping. IQOS scored higher in terms of subjective reward/satisfaction and was slightly preferred to the e-cigarette. : Short-term use of IQOS has a minimal impact on eCO, is equally effective in reducing cigarette craving and withdrawal symptoms as an e-cigarette, and is slightly preferred.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313326 | PMC |
http://dx.doi.org/10.3390/ijerph15122902 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!